Diabetes

  • A white, rectangular sticker device is in front of a blue, pen-shaped device.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic nets FDA nod for smart insulin pen app

    The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous glucose monitor for people who take multiple daily insulin injections.

    By • Nov. 22, 2024
  • A picture of five Ōura smart rings against a gold background.
    Image attribution tooltip
    Courtesy of Ōura
    Image attribution tooltip

    Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs

    The partnership will support data flows that enable people who use both companies’ devices to track how glucose levels affect other health metrics.

    By • Nov. 20, 2024
  • A picture of building with large glass windows and a parking lot, with flowers and grass in the foreground
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott opens plant in Ireland to boost Libre 3 sensor production

    More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities.

    By • Nov. 19, 2024
  • Two people stand in front of a sign taht says "Sequel is what's next in diabetes management."
    Image attribution tooltip
    Permission granted by Sequel Medtech
    Image attribution tooltip

    Dean Kamen, insulin pump pioneer, wants to shake up diabetes tech

    Kamen and Sequel Med Tech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology in the Twiist device.

    By • Updated 8 hours ago
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem, Insulet tout Type 2 expectations as tech attracts new users

    Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while Tandem plans to file a Type 2 submission by year’s end.

    By • Nov. 8, 2024
  • Professional photo of Teri Lawver
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom chief commercial officer to retire

    Teri Lawver is leaving the diabetes tech company during a challenging time, with sales slowing after a workforce restructuring.

    By • Oct. 25, 2024
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific, Edwards and Dexcom usher in second week of earnings

    Johnson & Johnson, Abbott and Intuitive Surgical made a mixed start to earnings season last week.

    By • Oct. 22, 2024
  • Promotional courtesy shot of a Cue Health Covid-19 test
    Image attribution tooltip
    Courtesy of Cue Health Press Kit
    Image attribution tooltip

    FDA labels Cue’s recall of COVID tests as Class II, revokes EUAs

    Cue Health began the recall of nearly 250,000 COVID-19 test kits in May, shortly after the FDA advised people at home and healthcare professionals not to use the products.

    By • Oct. 17, 2024
  • A person stands with a white, circular device attached to their upper arm.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott CEO sees ‘mass market potential’ for CGMs

    Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

    By • Oct. 16, 2024
  • J&J, Auris, Fortis
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J, Abbott and Intuitive kick off latest medtech earnings season

    From pulsed field ablation to diabetes tech and surgical robots, the updates will provide an early look at how key medtech markets performed last quarter.

    By • Oct. 14, 2024
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic recalls Minimed insulin pumps for reduced battery life

    The company said it received 170 reports of hyperglycemia and 11 reports of diabetic ketoacidosis in the U.S. that could be linked to the problem.

    By • Oct. 7, 2024
  • A nighttime shot of Chicago's downtown and river.
    Image attribution tooltip
    halbergman via Getty Images
    Image attribution tooltip

    Top medtech conferences in 2025

    The lineup includes industrywide conferences and events covering the latest medtech trends in diabetes, orthopedics, cardiac care and surgical robotics.

    By • Oct. 1, 2024
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott ramps up Libre 3 production amid shortages

    Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

    By • Sept. 20, 2024
  • A black reader is shown on top of a phone with a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics receives FDA clearance for one-year CGM

    Commercial partner Ascensia is in discussions with insulin pump manufacturers to create an automated insulin delivery system.

    By • Sept. 17, 2024
  • A rounded deivce that says "Accu-Chek" is in front of a phone showing a glucose prediction
    Image attribution tooltip
    Permission granted by Roche
    Image attribution tooltip

    Roche to launch new CGM in Europe in ‘coming weeks’

    Roche will roll out its Accu-Chek Smartguide in the Netherlands, Switzerland and Germany. The company hopes to stand out from competitors with features to predict hypoglycemia.

    By • Sept. 12, 2024
  • A person stands with a white, circular device attached to their upper arm.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Dexcom, Abbott OTC glucose sensors add to busy year for diabetes tech

    New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

    By • Sept. 11, 2024
  • A person eats oatmeal with berries, and a phone on the counter shows their current glucose levels.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott debuts Lingo over-the-counter CGM in the US

    Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor. 

    By • Sept. 6, 2024
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott partners with maker of ‘bionic pancreas’

    Abbott will integrate its latest glucose sensor with Beta Bionics’ automated insulin delivery system. 

    By • Sept. 5, 2024
  • Embecta CEO Dev Kurdikar stands at a podium that says "Nasdaq" while people clap around him.
    Image attribution tooltip
    Permission granted by Nasdaq
    Image attribution tooltip

    Embecta gets FDA nod for insulin patch pump

    Embecta’s first patch pump features a larger insulin reservoir, based on feedback from people with Type 2 diabetes.

    By • Sept. 3, 2024
  • A photo shows Insulet Chief Medical Officer Trang Ly
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip
    Q&A

    Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

    Automated insulin delivery for Type 2 patients can help change minds among physicians who have been reluctant to prescribe pump therapy, the chief medical officer said in an interview.

    By • Aug. 27, 2024
  • A person runs in a soccer field wearing two white devices taped to their upper arms.
    Image attribution tooltip
    Courtesy of Insulet
    Image attribution tooltip

    Insulet expands Omnipod 5 pump to people with Type 2 diabetes

    The FDA clearance marks the first automated insulin delivery system for people with Type 2 diabetes.

    By • Aug. 26, 2024
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom prices first over-the-counter glucose monitor

    Known as Stelo, the device is intended for people who don’t take insulin and costs $89 per month.

    By • Aug. 26, 2024
  • A person smiles while wearing a square device on their hip and a round device on their upper arm.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem warns iPhone app still draining insulin pump batteries

    Despite a software update in March, users are still reporting that the app is rapidly depleting their insulin pump batteries, causing unexpected shutdowns.

    By • Aug. 15, 2024
  • A person stands outside wearing a small, square device with a cord on their belt.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Abbott, Medtronic partner on diabetes tech

    Abbott will develop a glucose sensor that can only connect with Medtronic's insulin delivery technology.

    By • Aug. 7, 2024
  • A person playing a guitar in front of a microphone holds up a phone with a blood glucose reading on it.
    Image attribution tooltip
    Courtesy of Ascensia Diabetes Care
    Image attribution tooltip
    Q&A

    Ascensia’s new head of CGM talks plans for a 365-day sensor

    Brian Hansen recently joined Ascensia, which markets Senseonics’ implantable glucose sensors. The current version lasts 180 days, but Senseonics is seeking FDA approval for a one-year sensor.

    By • Aug. 6, 2024